Selected research
Market Outlook & Growth Opportunities
Global Anti-worm Medication Market Outlook and Growth Opportunities 2026
Market perspective
The global Anti-worm Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Anti-worm Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-worm Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-worm Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Anti-worm Medication market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Anti-worm Medication market include Boehringer Ingelheim, Chanelle Group, Dechra, Elanco, Fredun Pharmaceuticals Ltd, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Salius Pharma and Sequent Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anti-worm Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-worm Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-worm Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-worm Medication market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-worm Medication Segment by Company
Boehringer Ingelheim
Chanelle Group
Dechra
Elanco
Fredun Pharmaceuticals Ltd
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Salius Pharma
Sequent Scientific
Supharma Chem
Vetoquinol
Virbac
Zoetis
Bayer
GlaxoSmithKline
Zhongjia Pharmaceutical
Huazhong Pharmaceutical
Jiangsu Qihui
Merck Animal Health
Anti-worm Medication Segment by Type
Albenza
Vermox
Anti-worm Medication Segment by Application
Human
Veterinary
Anti-worm Medication Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Anti-worm Medication status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Anti-worm Medication market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Anti-worm Medication significant trends, drivers, influence factors in global and regions.
6. To analyze Anti-worm Medication competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-worm Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-worm Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-worm Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-worm Medication market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-worm Medication industry.
Chapter 3: Detailed analysis of Anti-worm Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Anti-worm Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Anti-worm Medication in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Anti-worm Medication Industry Trends
Table 2. Anti-worm Medication Industry Drivers
Table 3. Anti-worm Medication Industry Opportunities and Challenges
Table 4. Anti-worm Medication Industry Restraints
Table 5. Global Anti-worm Medication Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Anti-worm Medication Revenue Share by Company (2021-2026)
Table 7. Global Anti-worm Medication Sales Volume by Company (K Units) & (2021-2026)
Table 8. Global Anti-worm Medication Sales Volume Share by Company (2021-2026)
Table 9. Global Anti-worm Medication Average Price (US$/Unit) of Company (2021-2026)
Table 10. Global Anti-worm Medication Company Ranking, (2024-2026) & (USD Million)
Table 11. Global Anti-worm Medication Key Company Manufacturing Base & Headquarters
Table 12. Global Anti-worm Medication Company, Product Type & Application
Table 13. Global Anti-worm Medication Company Establishment Date
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Anti-worm Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Significant Companies of Albenza
Table 18. Significant Companies of Vermox
Table 19. Global Anti-worm Medication Sales Volume by Type 2021 VS 2025 VS 2032 (K Units)
Table 20. Global Anti-worm Medication Sales Volume by Type (2021-2026) & (K Units)
Table 21. Global Anti-worm Medication Sales Volume by Type (2027-2032) & (K Units)
Table 22. Global Anti-worm Medication Sales Volume Share by Type (2021-2026)
Table 23. Global Anti-worm Medication Sales Volume Share by Type (2027-2032)
Table 24. Global Anti-worm Medication Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 25. Global Anti-worm Medication Sales Value by Type (2021-2026) & (US$ Million)
Table 26. Global Anti-worm Medication Sales Value by Type (2027-2032) & (US$ Million)
Table 27. Global Anti-worm Medication Sales Value Share by Type (2021-2026)
Table 28. Global Anti-worm Medication Sales Value Share by Type (2027-2032)
Table 29. Significant Companies of Human
Table 30. Significant Companies of Veterinary
Table 31. Global Anti-worm Medication Sales Volume by Application 2021 VS 2025 VS 2032 (K Units)
Table 32. Global Anti-worm Medication Sales Volume by Application (2021-2026) & (K Units)
Table 33. Global Anti-worm Medication Sales Volume by Application (2027-2032) & (K Units)
Table 34. Global Anti-worm Medication Sales Volume Share by Application (2021-2026)
Table 35. Global Anti-worm Medication Sales Volume Share by Application (2027-2032)
Table 36. Global Anti-worm Medication Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Global Anti-worm Medication Sales Value by Application (2021-2026) & (US$ Million)
Table 38. Global Anti-worm Medication Sales Value by Application (2027-2032) & (US$ Million)
Table 39. Global Anti-worm Medication Sales Value Share by Application (2021-2026)
Table 40. Global Anti-worm Medication Sales Value Share by Application (2027-2032)
Table 41. Global Anti-worm Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units)
Table 42. Global Anti-worm Medication Sales by Region (2021-2026) & (K Units)
Table 43. Global Anti-worm Medication Sales Market Share by Region (2021-2026)
Table 44. Global Anti-worm Medication Sales by Region (2027-2032) & (K Units)
Table 45. Global Anti-worm Medication Sales Market Share by Region (2027-2032)
Table 46. Global Anti-worm Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 47. Global Anti-worm Medication Sales Value by Region (2021-2026) & (US$ Million)
Table 48. Global Anti-worm Medication Sales Value Share by Region (2021-2026)
Table 49. Global Anti-worm Medication Sales Value by Region (2027-2032) & (US$ Million)
Table 50. Global Anti-worm Medication Sales Value Share by Region (2027-2032)
Table 51. Global Anti-worm Medication Market Average Price (US$/Unit) by Region (2021-2026)
Table 52. Global Anti-worm Medication Market Average Price (US$/Unit) by Region (2027-2032)
Table 53. Global Anti-worm Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Table 54. Global Anti-worm Medication Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 55. Global Anti-worm Medication Sales by Country (2021-2026) & (K Units)
Table 56. Global Anti-worm Medication Sales Market Share by Country (2021-2026)
Table 57. Global Anti-worm Medication Sales by Country (2027-2032) & (K Units)
Table 58. Global Anti-worm Medication Sales Market Share by Country (2027-2032)
Table 59. Global Anti-worm Medication Sales Value by Country (2021-2026) & (US$ Million)
Table 60. Global Anti-worm Medication Sales Value Market Share by Country (2021-2026)
Table 61. Global Anti-worm Medication Sales Value by Country (2027-2032) & (US$ Million)
Table 62. Global Anti-worm Medication Sales Value Market Share by Country (2027-2032)
Table 63. Boehringer Ingelheim Company Information
Table 64. Boehringer Ingelheim Business Overview
Table 65. Boehringer Ingelheim Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Boehringer Ingelheim Anti-worm Medication Product Portfolio
Table 67. Boehringer Ingelheim Recent Development
Table 68. Chanelle Group Company Information
Table 69. Chanelle Group Business Overview
Table 70. Chanelle Group Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Chanelle Group Anti-worm Medication Product Portfolio
Table 72. Chanelle Group Recent Development
Table 73. Dechra Company Information
Table 74. Dechra Business Overview
Table 75. Dechra Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Dechra Anti-worm Medication Product Portfolio
Table 77. Dechra Recent Development
Table 78. Elanco Company Information
Table 79. Elanco Business Overview
Table 80. Elanco Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Elanco Anti-worm Medication Product Portfolio
Table 82. Elanco Recent Development
Table 83. Fredun Pharmaceuticals Ltd Company Information
Table 84. Fredun Pharmaceuticals Ltd Business Overview
Table 85. Fredun Pharmaceuticals Ltd Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Fredun Pharmaceuticals Ltd Anti-worm Medication Product Portfolio
Table 87. Fredun Pharmaceuticals Ltd Recent Development
Table 88. K.A. Malle Pharmaceuticals Company Information
Table 89. K.A. Malle Pharmaceuticals Business Overview
Table 90. K.A. Malle Pharmaceuticals Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. K.A. Malle Pharmaceuticals Anti-worm Medication Product Portfolio
Table 92. K.A. Malle Pharmaceuticals Recent Development
Table 93. Lasa Supergenerics Limited Company Information
Table 94. Lasa Supergenerics Limited Business Overview
Table 95. Lasa Supergenerics Limited Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Lasa Supergenerics Limited Anti-worm Medication Product Portfolio
Table 97. Lasa Supergenerics Limited Recent Development
Table 98. Salius Pharma Company Information
Table 99. Salius Pharma Business Overview
Table 100. Salius Pharma Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Salius Pharma Anti-worm Medication Product Portfolio
Table 102. Salius Pharma Recent Development
Table 103. Sequent Scientific Company Information
Table 104. Sequent Scientific Business Overview
Table 105. Sequent Scientific Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Sequent Scientific Anti-worm Medication Product Portfolio
Table 107. Sequent Scientific Recent Development
Table 108. Supharma Chem Company Information
Table 109. Supharma Chem Business Overview
Table 110. Supharma Chem Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Supharma Chem Anti-worm Medication Product Portfolio
Table 112. Supharma Chem Recent Development
Table 113. Vetoquinol Company Information
Table 114. Vetoquinol Business Overview
Table 115. Vetoquinol Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Vetoquinol Anti-worm Medication Product Portfolio
Table 117. Vetoquinol Recent Development
Table 118. Virbac Company Information
Table 119. Virbac Business Overview
Table 120. Virbac Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Virbac Anti-worm Medication Product Portfolio
Table 122. Virbac Recent Development
Table 123. Zoetis Company Information
Table 124. Zoetis Business Overview
Table 125. Zoetis Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Zoetis Anti-worm Medication Product Portfolio
Table 127. Zoetis Recent Development
Table 128. Bayer Company Information
Table 129. Bayer Business Overview
Table 130. Bayer Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Bayer Anti-worm Medication Product Portfolio
Table 132. Bayer Recent Development
Table 133. GlaxoSmithKline Company Information
Table 134. GlaxoSmithKline Business Overview
Table 135. GlaxoSmithKline Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. GlaxoSmithKline Anti-worm Medication Product Portfolio
Table 137. GlaxoSmithKline Recent Development
Table 138. Zhongjia Pharmaceutical Company Information
Table 139. Zhongjia Pharmaceutical Business Overview
Table 140. Zhongjia Pharmaceutical Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Zhongjia Pharmaceutical Anti-worm Medication Product Portfolio
Table 142. Zhongjia Pharmaceutical Recent Development
Table 143. Huazhong Pharmaceutical Company Information
Table 144. Huazhong Pharmaceutical Business Overview
Table 145. Huazhong Pharmaceutical Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Huazhong Pharmaceutical Anti-worm Medication Product Portfolio
Table 147. Huazhong Pharmaceutical Recent Development
Table 148. Jiangsu Qihui Company Information
Table 149. Jiangsu Qihui Business Overview
Table 150. Jiangsu Qihui Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Jiangsu Qihui Anti-worm Medication Product Portfolio
Table 152. Jiangsu Qihui Recent Development
Table 153. Merck Animal Health Company Information
Table 154. Merck Animal Health Business Overview
Table 155. Merck Animal Health Anti-worm Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Merck Animal Health Anti-worm Medication Product Portfolio
Table 157. Merck Animal Health Recent Development
Table 158. Key Raw Materials
Table 159. Raw Materials Key Suppliers
Table 160. Anti-worm Medication Distributors List
Table 161. Anti-worm Medication Customers List
Table 162. Research Programs/Design for This Report
Table 163. Authors List of This Report
Table 164. Secondary Sources
Table 165. Primary Sources
List of Figures
Figure 1. Anti-worm Medication Product Image
Figure 2. Global Anti-worm Medication Sales Value (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Anti-worm Medication Sales Value (2021-2032) & (US$ Million)
Figure 4. Global Anti-worm Medication Sales (2021-2032) & (K Units)
Figure 5. Global Anti-worm Medication Sales Average Price (US$/Unit) & (2021-2032)
Figure 6. Global Anti-worm Medication Company Revenue Ranking in 2025 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 9. Albenza Image
Figure 10. Vermox Image
Figure 11. Global Anti-worm Medication Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 12. Global Anti-worm Medication Sales Volume Share 2021 VS 2025 VS 2032
Figure 13. Global Anti-worm Medication Sales Volume Share by Type (2021-2032)
Figure 14. Global Anti-worm Medication Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 15. Global Anti-worm Medication Sales Value Share 2021 VS 2025 VS 2032
Figure 16. Global Anti-worm Medication Sales Value Share by Type (2021-2032)
Figure 17. Human Image
Figure 18. Veterinary Image
Figure 19. Global Anti-worm Medication Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 20. Global Anti-worm Medication Sales Volume Share 2021 VS 2025 VS 2032
Figure 21. Global Anti-worm Medication Sales Volume Share by Application (2021-2032)
Figure 22. Global Anti-worm Medication Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 23. Global Anti-worm Medication Sales Value Share 2021 VS 2025 VS 2032
Figure 24. Global Anti-worm Medication Sales Value Share by Application (2021-2032)
Figure 25. Global Anti-worm Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units)
Figure 26. Global Anti-worm Medication Sales Market Share by Region: 2021 VS 2025 VS 2032
Figure 27. Global Anti-worm Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 28. Global Anti-worm Medication Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 29. North America Anti-worm Medication Sales Value (2021-2032) & (US$ Million)
Figure 30. North America Anti-worm Medication Sales Value Share by Country (%), 2025 VS 2032
Figure 31. Europe Anti-worm Medication Sales Value (2021-2032) & (US$ Million)
Figure 32. Europe Anti-worm Medication Sales Value Share by Country (%), 2025 VS 2032
Figure 33. Asia-Pacific Anti-worm Medication Sales Value (2021-2032) & (US$ Million)
Figure 34. Asia-Pacific Anti-worm Medication Sales Value Share by Country (%), 2025 VS 2032
Figure 35. South America Anti-worm Medication Sales Value (2021-2032) & (US$ Million)
Figure 36. South America Anti-worm Medication Sales Value Share by Country (%), 2025 VS 2032
Figure 37. Middle East & Africa Anti-worm Medication Sales Value (2021-2032) & (US$ Million)
Figure 38. Middle East & Africa Anti-worm Medication Sales Value Share by Country (%), 2025 VS 2032
Figure 39. USA Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. USA Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. USA Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. Canada Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. Canada Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. Canada Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. Mexico Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. Mexico Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. Mexico Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. Germany Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. Germany Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. Germany Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. France Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. France Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. France Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. U.K. Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. U.K. Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. U.K. Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Italy Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Italy Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Italy Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Spain Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Spain Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Spain Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. Russia Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. Russia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. Russia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. Netherlands Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. Netherlands Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. Netherlands Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. Nordic Countries Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. Nordic Countries Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. Nordic Countries Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. China Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. China Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. China Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. Japan Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. Japan Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. Japan Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. South Korea Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. South Korea Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. South Korea Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. India Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. India Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. India Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Australia Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Australia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Australia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Southeast Asia Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Southeast Asia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Southeast Asia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Brazil Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Brazil Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Brazil Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Argentina Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Argentina Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Argentina Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Chile Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Chile Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Chile Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Colombia Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Colombia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Colombia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. Peru Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. Peru Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. Peru Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. Saudi Arabia Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. Saudi Arabia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. Saudi Arabia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Israel Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Israel Arabia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Israel Arabia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. UAE Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. UAE Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. UAE Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Turkey Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 115. Turkey Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 116. Turkey Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 117. Iran Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 118. Iran Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 119. Iran Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 120. Egypt Anti-worm Medication Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 121. Egypt Anti-worm Medication Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 122. Egypt Anti-worm Medication Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 123. Anti-worm Medication Value Chain
Figure 124. Manufacturing Cost Structure
Figure 125. Anti-worm Medication Sales Mode & Process
Figure 126. Direct Comparison with Distribution Share
Figure 127. Distributors Profiles
Figure 128. Years Considered
Figure 129. Research Process
Figure 130. Key Executives Interviewed
Scope & coverage.
Types
- Albenza
- Vermox
Applications
- Human
- Veterinary
Companies covered
- Boehringer Ingelheim
- Chanelle Group
- Dechra
- Elanco
- Fredun Pharmaceuticals Ltd
- K.A. Malle Pharmaceuticals
- Lasa Supergenerics Limited
- Salius Pharma
- Sequent Scientific
- Supharma Chem
- Vetoquinol
- Virbac
- Zoetis
- Bayer
- GlaxoSmithKline
- Zhongjia Pharmaceutical
- Huazhong Pharmaceutical
- Jiangsu Qihui
- Merck Animal Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Anti-worm Medication Sales Value (2021-2032)
- 1.2.2 Global Anti-worm Medication Sales Volume (2021-2032)
- 1.2.3 Global Anti-worm Medication Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Anti-worm Medication Market Dynamics
- 2.1 Anti-worm Medication Industry Trends
- 2.2 Anti-worm Medication Industry Drivers
- 2.3 Anti-worm Medication Industry Opportunities and Challenges
- 2.4 Anti-worm Medication Industry Restraints
3 Anti-worm Medication Market by Company
- 3.1 Global Anti-worm Medication Company Revenue Ranking in 2025
- 3.2 Global Anti-worm Medication Revenue by Company (2021-2026)
- 3.3 Global Anti-worm Medication Sales Volume by Company (2021-2026)
- 3.4 Global Anti-worm Medication Average Price by Company (2021-2026)
- 3.5 Global Anti-worm Medication Company Ranking (2024-2026)
- 3.6 Global Anti-worm Medication Company Manufacturing Base and Headquarters
- 3.7 Global Anti-worm Medication Company Product Type and Application
- 3.8 Global Anti-worm Medication Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Anti-worm Medication Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Anti-worm Medication Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Anti-worm Medication Market by Type
- 4.1 Anti-worm Medication Type Introduction
- 4.1.1 Albenza
- 4.1.2 Vermox
- 4.2 Global Anti-worm Medication Sales Volume by Type
- 4.2.1 Global Anti-worm Medication Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anti-worm Medication Sales Volume by Type (2021-2032)
- 4.2.3 Global Anti-worm Medication Sales Volume Share by Type (2021-2032)
- 4.3 Global Anti-worm Medication Sales Value by Type
- 4.3.1 Global Anti-worm Medication Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anti-worm Medication Sales Value by Type (2021-2032)
- 4.3.3 Global Anti-worm Medication Sales Value Share by Type (2021-2032)
5 Anti-worm Medication Market by Application
- 5.1 Anti-worm Medication Application Introduction
- 5.1.1 Human
- 5.1.2 Veterinary
- 5.2 Global Anti-worm Medication Sales Volume by Application
- 5.2.1 Global Anti-worm Medication Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-worm Medication Sales Volume by Application (2021-2032)
- 5.2.3 Global Anti-worm Medication Sales Volume Share by Application (2021-2032)
- 5.3 Global Anti-worm Medication Sales Value by Application
- 5.3.1 Global Anti-worm Medication Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anti-worm Medication Sales Value by Application (2021-2032)
- 5.3.3 Global Anti-worm Medication Sales Value Share by Application (2021-2032)
6 Anti-worm Medication Regional Sales and Value Analysis
- 6.1 Global Anti-worm Medication Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anti-worm Medication Sales by Region (2021-2032)
- 6.2.1 Global Anti-worm Medication Sales by Region: 2021-2026
- 6.2.2 Global Anti-worm Medication Sales by Region (2027-2032)
- 6.3 Global Anti-worm Medication Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Anti-worm Medication Sales Value by Region (2021-2032)
- 6.4.1 Global Anti-worm Medication Sales Value by Region: 2021-2026
- 6.4.2 Global Anti-worm Medication Sales Value by Region (2027-2032)
- 6.5 Global Anti-worm Medication Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Anti-worm Medication Sales Value (2021-2032)
- 6.6.2 North America Anti-worm Medication Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Anti-worm Medication Sales Value (2021-2032)
- 6.7.2 Europe Anti-worm Medication Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Anti-worm Medication Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Anti-worm Medication Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Anti-worm Medication Sales Value (2021-2032)
- 6.9.2 South America Anti-worm Medication Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Anti-worm Medication Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Anti-worm Medication Sales Value Share by Country, 2025 VS 2032
7 Anti-worm Medication Country-level Sales and Value Analysis
- 7.1 Global Anti-worm Medication Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Anti-worm Medication Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Anti-worm Medication Sales by Country (2021-2032)
- 7.3.1 Global Anti-worm Medication Sales by Country (2021-2026)
- 7.3.2 Global Anti-worm Medication Sales by Country (2027-2032)
- 7.4 Global Anti-worm Medication Sales Value by Country (2021-2032)
- 7.4.1 Global Anti-worm Medication Sales Value by Country (2021-2026)
- 7.4.2 Global Anti-worm Medication Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.9.2 France Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.16.2 China Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.19.2 India Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Anti-worm Medication Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Anti-worm Medication Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Anti-worm Medication Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Boehringer Ingelheim
- 8.1.1 Boehringer Ingelheim Company Information
- 8.1.2 Boehringer Ingelheim Business Overview
- 8.1.3 Boehringer Ingelheim Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Boehringer Ingelheim Anti-worm Medication Product Portfolio
- 8.1.5 Boehringer Ingelheim Recent Developments
- 8.2 Chanelle Group
- 8.2.1 Chanelle Group Company Information
- 8.2.2 Chanelle Group Business Overview
- 8.2.3 Chanelle Group Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Chanelle Group Anti-worm Medication Product Portfolio
- 8.2.5 Chanelle Group Recent Developments
- 8.3 Dechra
- 8.3.1 Dechra Company Information
- 8.3.2 Dechra Business Overview
- 8.3.3 Dechra Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Dechra Anti-worm Medication Product Portfolio
- 8.3.5 Dechra Recent Developments
- 8.4 Elanco
- 8.4.1 Elanco Company Information
- 8.4.2 Elanco Business Overview
- 8.4.3 Elanco Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Elanco Anti-worm Medication Product Portfolio
- 8.4.5 Elanco Recent Developments
- 8.5 Fredun Pharmaceuticals Ltd
- 8.5.1 Fredun Pharmaceuticals Ltd Company Information
- 8.5.2 Fredun Pharmaceuticals Ltd Business Overview
- 8.5.3 Fredun Pharmaceuticals Ltd Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Fredun Pharmaceuticals Ltd Anti-worm Medication Product Portfolio
- 8.5.5 Fredun Pharmaceuticals Ltd Recent Developments
- 8.6 K.A. Malle Pharmaceuticals
- 8.6.1 K.A. Malle Pharmaceuticals Company Information
- 8.6.2 K.A. Malle Pharmaceuticals Business Overview
- 8.6.3 K.A. Malle Pharmaceuticals Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.6.4 K.A. Malle Pharmaceuticals Anti-worm Medication Product Portfolio
- 8.6.5 K.A. Malle Pharmaceuticals Recent Developments
- 8.7 Lasa Supergenerics Limited
- 8.7.1 Lasa Supergenerics Limited Company Information
- 8.7.2 Lasa Supergenerics Limited Business Overview
- 8.7.3 Lasa Supergenerics Limited Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Lasa Supergenerics Limited Anti-worm Medication Product Portfolio
- 8.7.5 Lasa Supergenerics Limited Recent Developments
- 8.8 Salius Pharma
- 8.8.1 Salius Pharma Company Information
- 8.8.2 Salius Pharma Business Overview
- 8.8.3 Salius Pharma Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Salius Pharma Anti-worm Medication Product Portfolio
- 8.8.5 Salius Pharma Recent Developments
- 8.9 Sequent Scientific
- 8.9.1 Sequent Scientific Company Information
- 8.9.2 Sequent Scientific Business Overview
- 8.9.3 Sequent Scientific Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Sequent Scientific Anti-worm Medication Product Portfolio
- 8.9.5 Sequent Scientific Recent Developments
- 8.10 Supharma Chem
- 8.10.1 Supharma Chem Company Information
- 8.10.2 Supharma Chem Business Overview
- 8.10.3 Supharma Chem Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Supharma Chem Anti-worm Medication Product Portfolio
- 8.10.5 Supharma Chem Recent Developments
- 8.11 Vetoquinol
- 8.11.1 Vetoquinol Company Information
- 8.11.2 Vetoquinol Business Overview
- 8.11.3 Vetoquinol Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Vetoquinol Anti-worm Medication Product Portfolio
- 8.11.5 Vetoquinol Recent Developments
- 8.12 Virbac
- 8.12.1 Virbac Company Information
- 8.12.2 Virbac Business Overview
- 8.12.3 Virbac Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Virbac Anti-worm Medication Product Portfolio
- 8.12.5 Virbac Recent Developments
- 8.13 Zoetis
- 8.13.1 Zoetis Company Information
- 8.13.2 Zoetis Business Overview
- 8.13.3 Zoetis Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Zoetis Anti-worm Medication Product Portfolio
- 8.13.5 Zoetis Recent Developments
- 8.14 Bayer
- 8.14.1 Bayer Company Information
- 8.14.2 Bayer Business Overview
- 8.14.3 Bayer Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Bayer Anti-worm Medication Product Portfolio
- 8.14.5 Bayer Recent Developments
- 8.15 GlaxoSmithKline
- 8.15.1 GlaxoSmithKline Company Information
- 8.15.2 GlaxoSmithKline Business Overview
- 8.15.3 GlaxoSmithKline Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.15.4 GlaxoSmithKline Anti-worm Medication Product Portfolio
- 8.15.5 GlaxoSmithKline Recent Developments
- 8.16 Zhongjia Pharmaceutical
- 8.16.1 Zhongjia Pharmaceutical Company Information
- 8.16.2 Zhongjia Pharmaceutical Business Overview
- 8.16.3 Zhongjia Pharmaceutical Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Zhongjia Pharmaceutical Anti-worm Medication Product Portfolio
- 8.16.5 Zhongjia Pharmaceutical Recent Developments
- 8.17 Huazhong Pharmaceutical
- 8.17.1 Huazhong Pharmaceutical Company Information
- 8.17.2 Huazhong Pharmaceutical Business Overview
- 8.17.3 Huazhong Pharmaceutical Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Huazhong Pharmaceutical Anti-worm Medication Product Portfolio
- 8.17.5 Huazhong Pharmaceutical Recent Developments
- 8.18 Jiangsu Qihui
- 8.18.1 Jiangsu Qihui Company Information
- 8.18.2 Jiangsu Qihui Business Overview
- 8.18.3 Jiangsu Qihui Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Jiangsu Qihui Anti-worm Medication Product Portfolio
- 8.18.5 Jiangsu Qihui Recent Developments
- 8.19 Merck Animal Health
- 8.19.1 Merck Animal Health Company Information
- 8.19.2 Merck Animal Health Business Overview
- 8.19.3 Merck Animal Health Anti-worm Medication Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Merck Animal Health Anti-worm Medication Product Portfolio
- 8.19.5 Merck Animal Health Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anti-worm Medication Value Chain Analysis
- 9.1.1 Anti-worm Medication Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anti-worm Medication Sales Mode & Process
- 9.2 Anti-worm Medication Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anti-worm Medication Distributors
- 9.2.3 Anti-worm Medication Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst